Soloway Thomas P

EVP, Chief Operating Officer at Paratek Pharmaceuticals, Inc. · on record since Jan 8, 2013
Executive Vice President, CFO at Audentes Therapeutics, Inc. · on record since Feb 8, 2019
Director at Satsuma Pharmaceuticals, Inc. · on record since Jul 7, 2020
Director at Third Harmonic Bio, Inc. · on record since Sep 14, 2022

Insider trading activity of Soloway Thomas P

Transactions on record: 58; since Feb 3, 2009

Open-market buys: 0

Open-market sells: 3; $635.6K

Companies traded: 4; last filing Aug 14, 2025

Figures computed from official regulatory filings — .

Companies where Soloway Thomas P has traded

Third Harmonic Bio, Inc.8 tx · Aug 14, 2025
Satsuma Pharmaceuticals, Inc.6 tx · Jun 8, 2023
Audentes Therapeutics, Inc.21 tx · $13.5M · Jan 15, 2020
Paratek Pharmaceuticals, Inc.23 tx · $772.4K · Jul 18, 2013

Track record of Soloway Thomas P

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Soloway Thomas P

Co-insiders of Soloway Thomas P

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Third Harmonic Bio, Inc.Listing unverified	Aug 14, 2025	OtherD (derivative)	-120,166	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Jun 8, 2023	AwardD (derivative)	16,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	OtherD (derivative)	-13,667	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	OtherD (derivative)	-76,582	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	AwardD (derivative)	76,582	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	AwardD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Oct 27, 2022	AwardD (derivative)	13,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 7, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Dec 7, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jul 7, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-73,781	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-3,829	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-65,000	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	Other	-183,384	60.00 USD	$11M	Unusual size	SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-75,000	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-6,263	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	Exercise	144,669	2.76 USD	$399.3K	Unusual size	SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	Exercise	6,219	15.26 USD	$94.9K		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	ExerciseD (derivative)	-144,669	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	ExerciseD (derivative)	-6,219	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Dec 16, 2019	ExerciseD (derivative)	-41,321	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Third Harmonic Bio, Inc.Listing unverified	Aug 14, 2025	OtherD (derivative)	-120,166	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Jun 10, 2024	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Jun 8, 2023	AwardD (derivative)	16,250	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 8, 2023	OtherD (derivative)	-20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	OtherD (derivative)	-13,667	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	OtherD (derivative)	-76,582	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	AwardD (derivative)	76,582	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Mar 8, 2023	AwardD (derivative)	13,667	—	n/a (No price was disclosed in the filing)		SEC
Third Harmonic Bio, Inc.Listing unverified	Oct 27, 2022	AwardD (derivative)	13,667	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jun 7, 2022	AwardD (derivative)	30,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Dec 7, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Satsuma Pharmaceuticals, Inc.Listing unverified	Jul 7, 2020	AwardD (derivative)	20,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-73,781	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-3,829	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-65,000	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	Other	-183,384	60.00 USD	$11M	Unusual size	SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-75,000	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 15, 2020	OtherD (derivative)	-6,263	—	n/a (No price was disclosed in the filing)		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	Exercise	144,669	2.76 USD	$399.3K	Unusual size	SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	Exercise	6,219	15.26 USD	$94.9K		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	ExerciseD (derivative)	-144,669	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Jan 10, 2020	ExerciseD (derivative)	-6,219	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Audentes Therapeutics, Inc.Listing unverified	Dec 16, 2019	ExerciseD (derivative)	-41,321	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC